Daisue Construction Co., Ltd. (TYO:1814)

Market Cap	24.71B
Revenue (ttm)	89.03B
Net Income (ttm)	2.06B
Shares Out	10.45M
EPS (ttm)	197.43
PE Ratio	11.98
Forward PE	n/a
Dividend	108.00 (4.62%)
Ex-Dividend Date	Sep 29, 2025

Volume	56,900
Average Volume	41,335
Open	2,330.00
Previous Close	2,337.00
Day's Range	2,325.00 - 2,375.00
52-Week Range	1,351.00 - 2,366.00
Beta	0.28
RSI	69.97
Earnings Date	Aug 6, 2025

About CTI BioPharma

Daisue Construction Co., Ltd. operates as a construction company in Japan. The company is involved in the construction of condominiums, offices, logistics warehouses, factories, medical facilities, and wedding and funeral buildings. It also engages in the provision of repair, extension, renovation, and seismic diagnosis of existing buildings. The company was founded in 1937 and is headquartered in Osaka, Japan.

• Industry: Real Estate - Development
• Sector: Real Estate
• Founded: 1937
• Employees: 671
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 1814

Financial Performance

In 2024, Daisue Construction's revenue was 89.03 billion, an increase of 14.41% compared to the previous year's 77.82 billion. Earnings were 2.06 billion, an increase of 66.80%.